Ma C - Search Results

1

Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin.

Ma S, Ma R, Liu Z, Ma C, Shen X. Ma S, et al. Among authors: ma r, ma c. Eur J Med Chem. 2009 Oct;44(10):4010-20. doi: 10.1016/j.ejmech.2009.04.030. Epub 2009 May 4. Eur J Med Chem. 2009. PMID: 19464769

2

Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.

Ma C, Liu Z, Song H, Jiang R, He F, Ma S. Ma C, et al. Among authors: ma s. J Antibiot (Tokyo). 2010 Jan;63(1):3-8. doi: 10.1038/ja.2009.108. Epub 2009 Nov 13. J Antibiot (Tokyo). 2010. PMID: 19911029

3

Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.

Ma S, Jiao B, Ju Y, Zheng M, Ma R, Liu L, Zhang L, Shen X, Ma C, Meng Y, Wang H, Qi Y, Ma X, Cui W. Ma S, et al. Among authors: ma r, ma c, ma x. Eur J Med Chem. 2011 Feb;46(2):556-66. doi: 10.1016/j.ejmech.2010.11.035. Epub 2010 Nov 27. Eur J Med Chem. 2011. PMID: 21159410

4

WITHDRAWN: Novel azithromycin derivatives with the C-4″ bisamide side chains: synthesis and biological evaluation against gram-positive bacteria.

Cui W, An L, Ma C, Ma S, Cong C, Li X, Ma S. Cui W, et al. Among authors: ma c, ma s. J Antibiot (Tokyo). 2012 Feb 15. doi: 10.1038/ja.2012.3. Epub 2012 Feb 15. J Antibiot (Tokyo). 2012. Retraction in: J Antibiot (Tokyo). 2012 Jul;65(7):383. doi: 10.1038/ja.2012.35 PMID: 22334238 Retracted.

5

Developments of DNA-dependent Protein Kinase Inhibitors as Anticancer Agents.

Ma CC, Li H, Wan RZ, Liu ZP. Ma CC, et al. Mini Rev Med Chem. 2014 Oct 13. Online ahead of print. Mini Rev Med Chem. 2014. PMID: 25307307

6

Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.

Ma CC, Liu ZP. Ma CC, et al. Anticancer Agents Med Chem. 2017;17(3):395-403. doi: 10.2174/1871520616666160223120207. Anticancer Agents Med Chem. 2017. PMID: 26902599

7

Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.

Ma CC, Zhang CM, Tang LQ, Liu ZP. Ma CC, et al. Eur J Med Chem. 2018 May 10;151:9-17. doi: 10.1016/j.ejmech.2018.03.068. Epub 2018 Mar 23. Eur J Med Chem. 2018. PMID: 29601991

8

The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.

Cui YJ, Ma CC, Zhang CM, Tang LQ, Liu ZP. Cui YJ, et al. Eur J Med Chem. 2020 Feb 1;187:111968. doi: 10.1016/j.ejmech.2019.111968. Epub 2019 Dec 14. Eur J Med Chem. 2020. PMID: 31865012

9

SAR Investigation and Discovery of Water-Soluble 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as Potent Tubulin Polymerization Inhibitors.

Cui YJ, Liu C, Ma CC, Ji YT, Yao YL, Tang LQ, Zhang CM, Wu JD, Liu ZP. Cui YJ, et al. Among authors: ma cc. J Med Chem. 2020 Dec 10;63(23):14840-14866. doi: 10.1021/acs.jmedchem.0c01345. Epub 2020 Nov 17. J Med Chem. 2020. PMID: 33201714

10

The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.

Ma C, Liu P, Cui S, Gao C, Tan X, Liu Z, Xu R. Ma C, et al. Molecules. 2022 Sep 7;27(18):5804. doi: 10.3390/molecules27185804. Molecules. 2022. PMID: 36144542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,574 results

Search Page

Filters